BACIL PHARMA LTD.
BSE: 524516
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.11+75.8% | 0.06+17.5% | 0.05-94.5% | 1.00+1043.1% | 0.09+2823.3% | 0.00-99.5% | 0.56+5500.0% | 0.01 |
| Total Income | 0.11+75.8% | 0.06+17.5% | 0.05-94.5% | 1.00+1043.1% | 0.09+2823.3% | 0.00-99.5% | 0.56+5500.0% | 0.01 |
| EXPENSES | ||||||||
| Expenditure | 0.07+194.5% | 0.03-30.7% | 0.04-66.5% | 0.11+50.8% | 0.07+12.8% | 0.06-12.3% | 0.07+82.5% | 0.04 |
| Tax | -0.58 | 0.00-100.0% | 0.00-98.0% | 0.22 | 0.00 | — | 0.00 | — |
| PROFIT | ||||||||
| PBT | 0.04-0.8% | 0.04+113.0% | 0.02-97.9% | 0.89+5665.2% | 0.02+125.0% | -0.06-112.7% | 0.49+1723.3% | -0.03 |
| Net Profit | 0.62+1485.7% | 0.04+184.1% | 0.01-97.9% | 0.67+4214.2% | 0.02+125.0% | -0.06-112.8% | 0.48+1713.3% | -0.03 |
| KEY METRICS | ||||||||
| NPM % | 100.00%+39.22pp | 60.78%+35.64pp | 25.14%-41.56pp | 66.70%+49.03pp | 17.67%+117.67pp | -100.00%-186.43pp | 86.43% | — |
| EPS | 0.44+1366.7% | 0.03+200.0% | 0.01-97.9% | 0.48+140.0% | 0.20+300.0% | -0.10-112.2% | 0.82+8300.0% | -0.01 |
Corporate Events
Board MeetingBACPHAR
202626Jun
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗ Board MeetingBACPHAR
202525Aug
Board Meeting
Discussion on Appointment of M/s Sarang Shivajirao Chavan& A…
BSE Filing ↗ Board MeetingBACPHAR
202423Oct
Board Meeting
Consider and approve the un-audited financial results along …
BSE Filing ↗ Board MeetingBACPHAR
202415Oct
Board Meeting
acquisition of equity shares of M/s CNX Corporation Limited,…
BSE Filing ↗ Board MeetingBACPHAR
202427Sep
Board Meeting
increase in authorised share capital, alteration in Capital …
BSE Filing ↗ Board MeetingBACPHAR
202421May
Board Meeting
Consider and approve the Audited Financial Results, Auditor’…
BSE Filing ↗